A detailed history of Us Bancorp \De\ transactions in Bio N Tech Se stock. As of the latest transaction made, Us Bancorp \De\ holds 4,678 shares of BNTX stock, worth $466,490. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,678
Previous 25,690 81.79%
Holding current value
$466,490
Previous $2.06 Million 73.11%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$78.36 - $124.66 $1.65 Million - $2.62 Million
-21,012 Reduced 81.79%
4,678 $555,000
Q2 2024

Aug 06, 2024

BUY
$80.36 - $102.87 $134,442 - $172,101
1,673 Added 6.97%
25,690 $2.06 Million
Q1 2024

May 07, 2024

SELL
$88.96 - $112.35 $408,949 - $516,472
-4,597 Reduced 16.07%
24,017 $2.22 Million
Q4 2023

Feb 09, 2024

BUY
$90.91 - $112.75 $2.1 Million - $2.61 Million
23,119 Added 420.73%
28,614 $3.02 Million
Q3 2023

Nov 03, 2023

SELL
$98.5 - $125.08 $18,813 - $23,890
-191 Reduced 3.36%
5,495 $596,000
Q2 2023

Aug 09, 2023

BUY
$102.58 - $129.66 $67,600 - $85,445
659 Added 13.11%
5,686 $613,000
Q1 2023

May 09, 2023

BUY
$122.57 - $153.67 $44,125 - $55,321
360 Added 7.71%
5,027 $626,000
Q4 2022

Feb 13, 2023

SELL
$118.43 - $186.05 $42,753 - $67,164
-361 Reduced 7.18%
4,667 $701,000
Q3 2022

Oct 27, 2022

SELL
$127.65 - $183.11 $49,911 - $71,596
-391 Reduced 7.22%
5,028 $679,000
Q2 2022

Aug 01, 2022

BUY
$123.25 - $186.24 $127,317 - $192,385
1,033 Added 23.55%
5,419 $808,000
Q1 2022

May 11, 2022

BUY
$126.25 - $231.85 $41,915 - $76,974
332 Added 8.19%
4,386 $749,000
Q4 2021

Feb 11, 2022

BUY
$216.64 - $362.52 $248,486 - $415,810
1,147 Added 39.46%
4,054 $1.05 Million
Q3 2021

Nov 10, 2021

BUY
$205.93 - $447.23 $598,638 - $1.3 Million
2,907 New
2,907 $793,000
Q2 2021

Aug 05, 2021

SELL
$113.32 - $241.49 $339 - $724
-3 Closed
0 $0
Q1 2021

Apr 28, 2021

SELL
$85.73 - $119.5 $48,351 - $67,398
-564 Reduced 99.47%
3 $0
Q4 2020

Feb 04, 2021

BUY
$72.71 - $129.54 $41,226 - $73,449
567 New
567 $46,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $24.2B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.